Expressions of miR-146a and miR-155 in different samples of chronic hepatitis B patients.
10.11817/j.issn.1672-7347.2019.190366
- Author:
Yi OUYANG
1
,
2
;
Xiaoyu FU
1
,
2
;
Deming TAN
1
,
2
;
Shifang PENG
1
,
2
;
Lei FU
1
,
2
Author Information
1. Department of Infectious Diseases, Xiangya Hospital, Central South University
2. Hunan Key Laboratory of Viral Hepatitis, Changsha 410008, China.
- Publication Type:Journal Article
- MeSH:
Hepatitis B, Chronic;
genetics;
Humans;
Leukocytes, Mononuclear;
MicroRNAs;
genetics;
Real-Time Polymerase Chain Reaction
- From:
Journal of Central South University(Medical Sciences)
2019;44(8):845-849
- CountryChina
- Language:Chinese
-
Abstract:
To detect the levels of miR-146a and miR-155 in different samples from chronic hepatitis B (CHB), reveal whether there is a correlation between the 2 miRNAs in different samples, and to provide a theoretical basis for sample choice of miRNA research in liver.
Methods: Real-time PCR was conducted to examine the expression of miR-146a and miR-155 in the plasma, peripheral blood mononuclear cell (PBMC), and liver tissues from 41 CHB patients who underwent nucleoside analogues antiviral therapy for 104 weeks. Correlations between the levels of miR-146a and miR-155 among the 3 samples were analyzed.
Results: The expressions of miR-146a and miR-155 in the plasma, PBMC and liver tissues were significantly down-regulated at the 104th week than those at the baseline (all P<0.05). There was a correlation in the expression of miR-146a between plasma and liver tissues (r=0.560, P=0.007), PBMC and liver tissues (r=0.428, P=0.047) at baseline. There was a correlation in the expression of miR-155 between plasma and liver tissue (r=0.587, P=0.004), PBMC and liver tissue (r=0.483, P=0.023) at baseline. The expressions of miR-146a and miR-155 between the plasma and PBMC were not correlated (P>0.05).
Conclusion: Compared with PBMC, miR-146a and miR-155 from plasma can better reflect the expression in the liver tissues, suggesting that plasma can be applied in the mechanism research on miR-146a and miR-155 in the liver diseases instead of liver tissues.
